Delayed-onset endophthalmitis associated with Ex-PRESS mini glaucoma shunt®.

Yasir Ahmed, Avinash Pathengay, Harry W Flynn, Ryan Isom

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

The authors describe a 92-year-old man who developed delayed-onset endophthalmitis secondary to Bacillus sp. in his left eye 3 years after placement of an Ex-PRESS mini glaucoma shunt (Optonol Ltd., Neve Ilan, Israel). Seidel testing was positive over the Ex-PRESS mini glaucoma shunt. The patient underwent vitreous tap followed by intravitreal injections of vancomycin (1 mg/0.1 mL), ceftazadime (2.25 mg/0.1 mL), and dexamethasone (0.4 mg/0.1 mL), along with subconjunctival injection of vancomycin and tobramycin. The last recorded visual acuity was 3/200 in the left eye. With a 1-month follow-up, this case illustrates successful treatment with a vitreous tap and injection of intravitreal antibiotics. Vitrectomy and removal of the Ex-PRESS mini glaucoma shunt were not performed.

Original languageEnglish
JournalOphthalmic surgery, lasers & imaging : the official journal of the International Society for Imaging in the Eye
Volume43 Online
StatePublished - Aug 7 2012
Externally publishedYes

Fingerprint

Endophthalmitis
Glaucoma
Intravitreal Injections
Vancomycin
Tobramycin
Vitrectomy
Israel
Bacillus
Dexamethasone
Visual Acuity
Anti-Bacterial Agents
Injections
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

@article{36b10aae61804b3481490380ec8187ab,
title = "Delayed-onset endophthalmitis associated with Ex-PRESS mini glaucoma shunt{\circledR}.",
abstract = "The authors describe a 92-year-old man who developed delayed-onset endophthalmitis secondary to Bacillus sp. in his left eye 3 years after placement of an Ex-PRESS mini glaucoma shunt (Optonol Ltd., Neve Ilan, Israel). Seidel testing was positive over the Ex-PRESS mini glaucoma shunt. The patient underwent vitreous tap followed by intravitreal injections of vancomycin (1 mg/0.1 mL), ceftazadime (2.25 mg/0.1 mL), and dexamethasone (0.4 mg/0.1 mL), along with subconjunctival injection of vancomycin and tobramycin. The last recorded visual acuity was 3/200 in the left eye. With a 1-month follow-up, this case illustrates successful treatment with a vitreous tap and injection of intravitreal antibiotics. Vitrectomy and removal of the Ex-PRESS mini glaucoma shunt were not performed.",
author = "Yasir Ahmed and Avinash Pathengay and Flynn, {Harry W} and Ryan Isom",
year = "2012",
month = "8",
day = "7",
language = "English",
volume = "43 Online",
journal = "Ophthalmic Surgery Lasers and Imaging Retina",
issn = "2325-8160",
publisher = "Slack Incorporated",

}

TY - JOUR

T1 - Delayed-onset endophthalmitis associated with Ex-PRESS mini glaucoma shunt®.

AU - Ahmed, Yasir

AU - Pathengay, Avinash

AU - Flynn, Harry W

AU - Isom, Ryan

PY - 2012/8/7

Y1 - 2012/8/7

N2 - The authors describe a 92-year-old man who developed delayed-onset endophthalmitis secondary to Bacillus sp. in his left eye 3 years after placement of an Ex-PRESS mini glaucoma shunt (Optonol Ltd., Neve Ilan, Israel). Seidel testing was positive over the Ex-PRESS mini glaucoma shunt. The patient underwent vitreous tap followed by intravitreal injections of vancomycin (1 mg/0.1 mL), ceftazadime (2.25 mg/0.1 mL), and dexamethasone (0.4 mg/0.1 mL), along with subconjunctival injection of vancomycin and tobramycin. The last recorded visual acuity was 3/200 in the left eye. With a 1-month follow-up, this case illustrates successful treatment with a vitreous tap and injection of intravitreal antibiotics. Vitrectomy and removal of the Ex-PRESS mini glaucoma shunt were not performed.

AB - The authors describe a 92-year-old man who developed delayed-onset endophthalmitis secondary to Bacillus sp. in his left eye 3 years after placement of an Ex-PRESS mini glaucoma shunt (Optonol Ltd., Neve Ilan, Israel). Seidel testing was positive over the Ex-PRESS mini glaucoma shunt. The patient underwent vitreous tap followed by intravitreal injections of vancomycin (1 mg/0.1 mL), ceftazadime (2.25 mg/0.1 mL), and dexamethasone (0.4 mg/0.1 mL), along with subconjunctival injection of vancomycin and tobramycin. The last recorded visual acuity was 3/200 in the left eye. With a 1-month follow-up, this case illustrates successful treatment with a vitreous tap and injection of intravitreal antibiotics. Vitrectomy and removal of the Ex-PRESS mini glaucoma shunt were not performed.

UR - http://www.scopus.com/inward/record.url?scp=84864525704&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84864525704&partnerID=8YFLogxK

M3 - Article

C2 - 22785601

AN - SCOPUS:84864525704

VL - 43 Online

JO - Ophthalmic Surgery Lasers and Imaging Retina

JF - Ophthalmic Surgery Lasers and Imaging Retina

SN - 2325-8160

ER -